Thermo Fisher Scientific Inc. (TMO) Market Cap & Valuation Ratios
Thermo Fisher Scientific Inc. (TMO) has a market cap of $249.1B, a trailing P/E of 36.2 and a price-to-sales ratio of 5.4, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TMOThermo Fisher Scientific Inc.Follow TMO — free
—
Price chart with a free account
- Market cap
- 249.1B
- P/E TTM
- 36.2
- Dividend yield
- 0.3%
- 52-week
- —
- Next earnings
- 27 Jan, in 95 days
Peers
diagnostics & research · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| TMO | 249 | 36.2 | 6.2 | 25.9 | 2.9% | +7% | 18% | 9% |
| DHR | 162 | 37.7 | 7.1 | 23.3 | 3.5% | +6% | 20% | 7% |
| NTRA | 58 | — | 21.1 | — | 0.1% | +38% | -11% | -51% |
| A | 49 | 34.1 | 6.9 | 26.7 | 2.6% | +9% | 22% | 16% |
| IQV | 46 | 34.7 | 3.5 | 17.7 | 4.7% | +8% | 13% | 9% |
| WAT | 45 | — | 10.6 | 52.1 | 0.9% | +52% | 7% | 2% |
| IDXX | 44 | 39.4 | 9.9 | 27.9 | 2.8% | +13% | 32% | 49% |
| ILMN | 41 | 50.3 | 9.2 | 36.0 | 2.3% | +5% | 20% | 19% |
| MTD | 33 | 37.6 | 8.6 | 28.4 | 2.6% | +7% | 28% | 49% |
| LH | 27 | 27.2 | 2.3 | 14.8 | 4.3% | +6% | 10% | 9% |
| DGX | 27 | 24.1 | 2.6 | 13.6 | 5.2% | +9% | 15% | 11% |
| Median of these 10 | 36.2 | 7.9 | 26.7 | 2.7% | +8% | 17% | 10% |
P/E 36.2 vs. a peer median of 36.2; EV/Sales 6.2 vs. 7.9. TMO's own P/E sits at the 87th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesNTRA and WAT have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Thermo Fisher Scientific Inc. — questions
- What is Thermo Fisher Scientific Inc.'s market cap?
- $249.1B.
- What is Thermo Fisher Scientific Inc.'s P/E ratio?
- 36.2 on trailing twelve-month earnings to 2026-06-30.
- What is Thermo Fisher Scientific Inc.'s price-to-sales ratio?
- 5.4.
Every figure on this page comes from Thermo Fisher Scientific Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.